Julian Baker is Managing Partner of Baker Bros. Advisors LP (“BBA”) a biotechnology-focused, long-term investment adviser. Mr. Baker founded BBA, together with his brother and Co-Managing Partner Dr. Felix Baker, in 2000. Prior to BBA, Mr. Baker and his brother were portfolio managers of a biotech-focused investment partnership at Tisch Financial Management from 1994 to 1999. Previously, Mr. Baker was employed from 1988 to 1993 by the private equity investment arm of Credit Suisse First Boston Corporation. Mr. Baker serves several public companies including as Chairman of Madrigal Pharmaceuticals, Chairman of Incyte Pharmaceuticals, Chairman of Denali Therapeutics, and as a Director of Acadia Pharmaceuticals. Mr. Baker also serves on several private company and non-profit boards. Mr. Baker holds an A.B. Magna Cum Laude from Harvard University.